Sighregen Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Sighregen General Information
Description
Developer of retinal pigment epithelial medicine based in Kobe, Japan.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
- 5-2 Minatojima Minamimachi 5-chome
- Chuo-ku
- Kobe
- Japan
Primary Industry
Drug Discovery
Corporate Office
- 5-2 Minatojima Minamimachi 5-chome
- Chuo-ku
- Kobe
- Japan
Sighregen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sighregen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sighregen FAQs
-
When was Sighregen founded?
Sighregen was founded in 2014.
-
Where is Sighregen headquartered?
Sighregen is headquartered in Kobe, Japan.
-
What industry is Sighregen in?
Sighregen’s primary industry is Drug Discovery.
-
Is Sighregen a private or public company?
Sighregen is a Private company.
-
What is Sighregen’s current revenue?
The current revenue for Sighregen is .
-
Who are Sighregen’s investors?
Healios (Drug Discovery) and Sumitomo Pharma have invested in Sighregen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process